文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

IL-33 and soluble ST2 in follicular fluid are associated with premature ovarian insufficiency.

作者信息

Tang Maoxing, Sun Xuedong, Li Ping, Deng Weifen, Zhan Xi, Sun Peng, Shi Yuhua

机构信息

Department of Reproductive Medicine, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.

Department of Neurology, Nanfang Hospital, Southern Medical University, Guangzhou, China.

出版信息

Front Endocrinol (Lausanne). 2024 Dec 6;15:1463371. doi: 10.3389/fendo.2024.1463371. eCollection 2024.


DOI:10.3389/fendo.2024.1463371
PMID:39713054
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11659004/
Abstract

BACKGROUND: Premature ovarian insufficiency (POI) is a common reproductive disease that is associated with chronic inflammation in ovaries. Interleukin 33 (IL-33) is a pro-inflammatory IL-1 family cytokine, and functions as an alarmin reflecting inflammatory reaction. Our study aimed to investigate levels of IL-33 and its soluble receptor (sST2) in both follicular fluid (FF) and paired serum during different stages of POI, and evaluate their predictive potentials for POI. Furthermore, we attempted to determine whether IL-33 and sST2 were associated with embryo quality. METHODS: A total of 148 women, including 50 patients with biochemical POI (bPOI) (10 IU/L < follicle-stimulating hormone (FSH) ≤ 25 IU/L), 46 patients with POI (25 IU/L<FSH ≤ 40 IU/L) and 52 age-matched control women with normal ovarian reserve were involved in this study. FF and paired serum were collected from these women. IL-33 and sST2 were measured using quantitative sandwich enzyme-linked immunosorbent assay. RESULTS: FF IL-33 levels were significantly increased in bPOI and POI patients compared to controls. They exhibited positive associations with FSH and luteinizing hormone (LH), whereas negative correlations with anti-Müllerian hormone (AMH), estradiol (E), testosterone (T) and antral follicle count (AFC). Receiver operating characteristic (ROC) curve analysis showed that for POI prediction, FF IL-33 had a better predictive accuracy (AUC 0.901) with high sensitivity (82.61%) and good specificity (84.62%) than those for bPOI prediction. IL-33 levels in paired serum did not differ among three groups. Regarding sST2, its levels in FF declined with POI progression. Contrarily, they showed negative associations with FSH and LH, but positive correlations with AMH, E2, T and AFC. ROC analysis revealed that FF sST2 had comparatively weak potentials for both bPOI and POI prediction compared to those of FF IL-33. Similarly, there was no significant alteration of sST2 in paired serum among three groups. Additionally, Spearman's correlation analysis revealed that FF IL-33 levels were negatively associated with the rates of Day-3 good-quality embryos (r=-0.206, =0.012), whereas FF sST2 did not. CONCLUSION: Our study revealed an increased abundance of FF IL-33, whereas an sST2 deficiency with POI development. This implies that IL-33 and sST2 levels might be associated with the development of POI.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6b6/11659004/dfcca5d0cd67/fendo-15-1463371-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6b6/11659004/6d48f2e2a09a/fendo-15-1463371-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6b6/11659004/ca3f23c8dbc9/fendo-15-1463371-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6b6/11659004/a7f9cee0b2f5/fendo-15-1463371-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6b6/11659004/dfcca5d0cd67/fendo-15-1463371-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6b6/11659004/6d48f2e2a09a/fendo-15-1463371-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6b6/11659004/ca3f23c8dbc9/fendo-15-1463371-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6b6/11659004/a7f9cee0b2f5/fendo-15-1463371-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6b6/11659004/dfcca5d0cd67/fendo-15-1463371-g004.jpg

相似文献

[1]
IL-33 and soluble ST2 in follicular fluid are associated with premature ovarian insufficiency.

Front Endocrinol (Lausanne). 2024-12-6

[2]
Study of Serum Anti-Mullerian Hormone in the Diagnosis of Ovarian Reserve Function in Patients with Premature Ovarian Insufficiency.

Biomed Res Int. 2022

[3]
New theca-cell marker insulin-like factor 3 is associated with premature ovarian insufficiency.

Fertil Steril. 2021-2

[4]
Ovarian Reserve Markers in Premature Ovarian Insufficiency: Within Different Clinical Stages and Different Etiologies.

Front Endocrinol (Lausanne). 2021

[5]
Oocyte matched follicular fluid anti-Müllerian hormone is an excellent predictor of live birth after fresh single embryo transfer.

Hum Reprod. 2019-11-1

[6]
Using anti-Müllerian hormone to predict premature ovarian insufficiency: a retrospective cross-sectional study.

Front Endocrinol (Lausanne). 2024-11-19

[7]
Dysregulated cytokine profile associated with biochemical premature ovarian insufficiency.

Am J Reprod Immunol. 2020-10

[8]
Anti-müllerian hormone compared with other ovarian markers after childhood cancer treatment.

Acta Oncol. 2018-12-18

[9]
Plasminogen activator inhibitor 1 is a novel predictor in human serum/follicular fluid for diminished ovarian reserve.

BMC Womens Health. 2025-4-29

[10]
Elevated LH levels draw a stronger distinction than AMH in premature ovarian insufficiency.

Climacteric. 2014-4

本文引用的文献

[1]
Intestinal IL-33 promotes microbiota-derived trimethylamine N -oxide synthesis and drives metabolic dysfunction-associated steatotic liver disease progression by exerting dual regulation on HIF-1α.

Hepatology. 2024-7-10

[2]
Immunophenotypic profiles and inflammatory markers in Premature Ovarian Insufficiency.

J Reprod Immunol. 2024-8

[3]
Activation of interleukin 33-NFκB axis in granulosa cells during atresia and its role in disposal of atretic follicles†.

Biol Reprod. 2024-5-9

[4]
New insight into the role of macrophages in ovarian function and ovarian aging.

Front Endocrinol (Lausanne). 2023

[5]
The Role of Lifestyle and Dietary Factors in the Development of Premature Ovarian Insufficiency.

Antioxidants (Basel). 2023-8-11

[6]
Potential Therapeutic Options for Premature Ovarian Insufficiency: Experimental and Clinical Evidence.

Reprod Sci. 2023-12

[7]
The T 22-mediated IL-22 deficiency associated with premature ovarian insufficiency.

Am J Reprod Immunol. 2023-4

[8]
Primary Ovarian Insufficiency.

N Engl J Med. 2023-1-12

[9]
The role of oxidative stress in ovarian aging: a review.

J Ovarian Res. 2022-9-1

[10]
IL-33/ST2 axis in autoimmune disease.

Cytokine. 2022-10

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索